{
  "folder": "IC-027",
  "content": "{{knowledge objective\n|Identifiant=OIC-027-17-A\n|Item_parent=Prevention of foetal risks: infection, drugs, toxic substances, irradiation\n|Item_parent_short=Prevention of foetal risks: infection, drugs, toxic substances, irradiation\n|Rank=A\n|Title=Human immunodeficiency virus (HIV): knowing the elements of prevention through screening\n|Description=Knowing the methods of maternal screening\n|Rubric=Management\n|Contributors=Alexandre Vivanti, Philippe Deruelle\n|Ordre=17}}\nFor the sake of the child (and the mother), the mother's [[Interpretation of an SD-236 serology result|HIV status]] should be known. Screening should be offered systematically at the beginning of pregnancy (at the time of notification), even if it is not compulsory.",
  "question": {
    "question": "At the beginning of pregnancy, screening for HIV status should be offered systematically",
    "option_a": "Only to women who have had previous HIV exposure",
    "option_b": "To all pregnant women, regardless of risk factors",
    "option_c": "To women who have traveled to areas with high HIV prevalence",
    "option_d": "Only to women who have been tested positive for HIV in the past",
    "correct_option": "B"
  }
}